IDH1 and oligodendroglioma: Treatment of an oligodendroglioma cell line harboring an endogenous IDH1-R132H mutation with this inhibitor reduced growth in soft agar by 40%–60% and impeded the growth of xenograft tumors derived from that cell line in mice.